SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject8/9/2002 12:16:52 PM
From: scaram(o)uche  Read Replies (2) of 724
 
Inventories decreased slightly to $15,074,000 at June 30, 2002 from $15,168,000
at December 31, 2001. Raw materials and sub-assemblies decreased 6.7% and
work-in-process decreased 29.8% while finished goods increased 19.7%. The
decrease in work-in-process was due primarily to the shipment of multiple,
sterilizable-in-place, fermentation systems during the period. The increase in
finished goods resulted primarily from increased inventories of freezers due to
the need to have adequate supplies available for sale in the United States, a
new freezer market for the Company, and due to a buildup of freezers in Europe
as a result of increased production relative to shipments during the quarter
ended June 30, 2002.

(10-Q is out)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News